Global Prostate Cancer Testing Market 2018-2022

#Snapshot img { margin: 10px !important; } Below are some of the key findings from the prostate cancer testing market research reportSee the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.Get a FREE sample now!Global prostate cancer testing industry overviewThe increasing incidences of prostate cancer is one of the primary factors that will trigger the growth of the prostate cancer testing market in the coming years. The incidence of prostate cancer is increasing worldwide and is the second most common cancer diagnosed in men. It is estimated that every year approximately one million new cases of prostate cancer are diagnosed worldwide. Over the last few decades, the incidence rate of prostate cancer has increased owing to the rising older population, growing urbanization, and associated lifestyle changes. This will further lead the prostate cancer testing market to grow at a CAGR of close to 11% by 2022.The increasing focus on biomarker research is one of the key trends in the prostate cancer testing market. The development of biomarkers has accelerated with the recent developments in high throughput technology platforms in proteomics, genomics, and immunology. The manufacturers are focusing on developing prostate cancer biomarkers which can foretell disease aggressiveness and drive better treatment decisions.Top prostate cancer testing companies covered in this market research reportThe prostate cancer testing market is moderately fragmented with companies focusing on increasing R&D and investments in the development of innovative products. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this prostate cancer testing industry analysis report will aid clients to form effective business strategies for strengthening their position in the market.The report offers a complete analysis of various companies including:C. R. BardCook MedicalDanaherF. Hoffmann-La RocheMDxHealthOPKO HealthSiemens HealthcareProstate cancer testing market segmentation based on geographic regionsAmericasAPACEMEAWith a complete study of the growth opportunities for the companies, the Americas will account for the highest prostate cancer testing share throughout the forecast period. However, the APAC region is likely to contribute the highest incremental growth during the forecast period primarily due to the presence of a huge patient pool and the growing awareness about prostate cancer.Prostate cancer testing market segmentation based on productBiomarkersBiopsyImagingThe biomarkers segment will account for the highest growth in the market primarily supported by the increasing awareness about the clinical benefits of advanced biomarkers. Additionally, the report also provides an accurate prediction of the contribution of the various products segments impacting the growth of the prostate cancer testing market size.Key highlights of the global prostate cancer testing market for the forecast years 2018-2022:CAGR of the market during the forecast period 2018-2022Detailed information on factors that will accelerate the growth of the prostate cancer testing market during the next five yearsPrecise estimation of the global prostate cancer testing market size and its contribution to the parent marketAccurate predictions on upcoming trends and changes in consumer behaviorGrowth of the prostate cancer testing industry across the Americas, APAC, and EMEAA thorough analysis of the market’s competitive landscape and detailed information on several vendorsComprehensive details on the factors that will challenge the growth of prostate cancer testing companiesWe can help! Our analysts can customize this market research report to meet your requirements. Get in touch 

以下为前列腺癌检测市场调研报告的关键发现摘要：请参阅完整的目录和展览列表，以及报告中的精选插图和示例页面。现在免费获取样本！全球前列腺癌检测行业概述：前列腺癌发病率的不断上升将是未来几年推动前列腺癌检测市场增长的主要因素之一。全球范围内，前列腺癌的发病率正在上升，并且是男性中第二常见被诊断出的癌症。据估计，全球每年大约有大约一百万例新的前列腺癌病例被诊断出来。在过去几十年中，由于老年人口的增长、城市化进程的加速以及相关生活方式的改变，前列腺癌的发病率有所上升。这将进一步推动前列腺癌检测市场以接近11%的复合年增长率增长。对生物标志物研究的日益关注是前列腺癌检测市场的主要趋势之一。随着蛋白质组学、基因组学和免疫学高通量技术平台的最新发展，生物标志物的研究得到了加速。制造商正致力于开发能够预测疾病侵袭性和推动更好治疗决策的前列腺癌生物标志物。本市场调研报告涵盖了以下主要前列腺癌检测公司：C. R. Bard、Cook Medical、Danaher、F. Hoffmann-La Roche、MDxHealth、OPKO Health、Siemens Healthcare。前列腺癌检测市场按照地理区域进行细分：美洲、亚太地区、中东和非洲。通过对公司增长机会的全面研究，美洲将在预测期间占据前列腺癌检测市场最高的份额。然而，亚太地区预计将在预测期间贡献最高的增量增长，这主要得益于庞大的患者群体和对前列腺癌认识的不断增长。前列腺癌检测市场按照产品进行细分：生物标志物、活检、成像。生物标志物部分将在市场中实现最高的增长，这主要得益于对高级生物标志物临床益处的认识不断提高。此外，报告还提供了对影响前列腺癌检测市场规模增长的各个产品细分市场的准确预测。以下是全球前列腺癌检测市场在2018-2022年预测期间的关键亮点：市场在预测期间的复合年增长率、将在未来五年内加速市场增长的各项因素的具体信息、全球前列腺癌检测市场规模及其对母市场的贡献的精确估计、对即将到来的趋势和消费者行为变化的准确预测、美洲、亚太地区和欧洲、中东和非洲前列腺癌检测行业的增长、市场竞争格局的全面分析以及多个供应商的详细信息、对挑战前列腺癌检测公司增长的各项因素的全面细节。我们可提供帮助！我们的分析师可以根据您的需求定制本市场调研报告。请联系我们。